A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma
Clinical trial NCT02541383 · COMPLETED
Trial details
- NCT number
- NCT02541383
- Sponsor
- Intergroupe Francophone du Myelome
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2020-08-27
- Enrollment
- 1085
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.